Autres langues EUROAPI London S.E.

Actions

0EAP

FR0014008VX5

Produits pharmaceutiques

Marché Fermé - London S.E. Autres places de cotation 17:30:00 19/06/2026			Varia. 5j.	Varia. 1 janv.
1,261 ^EUR	+1,04%		-1,25%	-44,28%

04/06	Transcript : Euroapi S.A. - Shareholder/Analyst Call
14/05	Airbus, Bastide, Euroapi, Invibes Advertising, Vinci...les valeurs à suivre aujourd'hui à Paris

Autres langues

27/05	Combined General Meeting of May 27, 2026
13/05	Euroapi says no decision made on Brindisi site amid buyer discussions
13/05	EUROAPI statement regarding the Brindisi site
30/04	EUROAPI : Availibility of preparatory documents
30/04	EUROAPI : Liquidity contract May 2026
30/04	EUROAPI : Liquidity Contract
30/04	EUROAPI_Liquidity Contract
29/04	Availabilty of 2026 AGM preparatory documents
27/03	EUROAPI : Availability of the 2025 Universal Registration Document, including the Annual Financial Report
27/03	EUROAPI - Availability of the 2025 Universal Registration Document
03/03	EUROAPI : Full-Year 2025 results
03/03	Euroapi FY Ebitda EUR 9.9 mln
03/03	2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
03/03	Euroapi S.A. Provides Earnings Guidance for the Fy 2026
03/03	Euroapi S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
17/12	Morning Meeting: La geopolitica pesa sull'Europa, Wall Street guarda a Micron e all'inflazione
16/12	Euroapi cuts FY net sales outlook
16/12	Euroapi expects mid-single digit decrease in 2025 net sales
16/12	Market update
16/12	Euroapi S.A. Revises Sales Guidance for Full Year 2025
10/12	Euroapi S.A. Announces Board and Committee Changes
10/12	Tristan Imbert co-opted as Independent Director
23/10/25	Euroapi and Abolis Biotechnologies enter into partnership
23/10/25	Abolis Biotechnologies and EUROAPI Enters into Partnership to Accelerate Pharmaceutical Innovation and Restore European Constitution
23/10/25	With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of health sovereignty